Matthew P. Gourmand was named President and Chief Executive Officer of Omega Healthcare Investors Inc. As of November 7, 2026, Omega Healthcare Investors Inc has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 21, 2026 to October 1, 2026, naming 2 appointments (Form 8-K, May 21, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Omega Healthcare Investors Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Omega Healthcare Investors Inc reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-21 to 2026-10-01. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Omega Healthcare Investors Inc files it.
Also on the record for Omega Healthcare Investors Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 6, 2026 | Stake report, Schedule 13G/A, by Cohen & Steers, Inc. | 10.33% of the class | 5%+ stakes | Source |
| October 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 12.3% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by Cohen & Steers, Inc. | 7.85% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.3% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 9.18% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Cohen & Steers, Inc. | 4.64% of the class | 5%+ stakes | Source |
| January 8, 2026 | Stake report, Schedule 13G/A, by Cohen & Steers, Inc. | 4.64% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by Cohen & Steers, Inc. | 5.92% of the class | 5%+ stakes | Source |
| November 10, 2025 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5% of the class | 5%+ stakes | Source |
| August 11, 2025 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5% of the class | 5%+ stakes | Source |
| July 8, 2025 | Stake report, Schedule 13G/A, by COHEN & STEERS, INC. | 3.39% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Omega Healthcare Investors Inc now and the warning signs.
Free to see. No signup.
Keep reading
More on Omega Healthcare Investors Inc and the records around it.
Omega Healthcare Investors Inc elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Cohen & Steers, Inc. also filed stake reports on 37 other companies: RAYONIER INC. (Oct 2026), ARKO Petroleum Corp. (Aug 2026), BXP, Inc. (Aug 2026)
- STATE STREET CORPORATION also filed stake reports on 343 other companies: TRADE DESK INC/THE (Oct 2026), CENTRUS ENERGY CORP (Sep 2026), ACADIA PHARMACEUTICALS INC (Aug 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
Watch Omega Healthcare Investors Inc
Get an email when Omega Healthcare Investors Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Omega Healthcare Investors Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Omega Healthcare Investors Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Omega Healthcare Investors Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-01 | Reported | not named in the filing | 8-K, 2026-10-01 | ||
| 2026-05-21 | In | President and Chief Executive Officer | 8-K, 2026-05-21 | ||
| 2026-05-21 | In | Chief Financial Officer | 8-K, 2026-05-21 |
Who leads Omega Healthcare Investors Inc, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Neal A. Ballew, appointed (filed 2026-05-21).
- President and Chief Executive Officer: Matthew P. Gourmand, appointed (filed 2026-05-21).
New leaders reset buying decisions — get the Full Report on Omega Healthcare Investors Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President and Chief Executive Officer at Omega Healthcare Investors Inc, with the record behind each one.
Find candidates like President and Chief Executive Officer at Omega Healthcare Investors IncEvery change, in the filing's words
Reported
Following Mr. Gourmand's appointment, the number of directors constituting the entire Board remains at eight.
- As previously disclosed, effective October 1, 2026, the Board of Directors (the "Board") of Omega Healthcare Investors, Inc. (the "Company") appointed Matthew P. Gourmand, the Company's President, to serve as the Company's President and Chief Executive Officer, to succeed C. Taylor Pickett as Chief Executive Officer upon Mr. Pickett's retirement.
- In connection therewith, also effective October 1, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Mr. Gourmand as a director of the Company to fill the vacancy created by Mr. Pickett's retirement from the Board for the remaining term of Mr. Pickett's directorship expiring in 2027.
- Mr. Pickett's retirement is not the result of any disagreement with the Company on any matter related to the Company's operations, policies or practices.
- As of the time of this filing, the Board does not expect to appoint Mr. Gourmand to any committees of the Board.
- Mr. Gourmand (age 51) has served as the Company's President since January 1, 2025.
- Prior to that, Mr. Gourmand had served as the Company's Senior Vice President of Corporate Strategy & Investor Relations since January 2021 and, prior to that, as the Company's Senior Vice President of Investor Relations since October 2017.
Appointed: Matthew P. Gourmand, President and Chief Executive Officer
The Board also appointed Matthew P. Gourmand, the Company's President, to serve as the Company's President and Chief Executive Officer, effective as of the CEO Transition Date.
Appointed: Neal A. Ballew, Chief Financial Officer
The Board also appointed Neal A. Ballew, the Company's Senior Vice President and Chief Accounting Officer, to serve as the Company's Chief Financial Officer, and Lucas M. Golem, the Company's Vice President of Financial Reporting, to succeed Mr. Ballew's position and serve as the Company's Chief Accounting Officer, both effective as of the CFO Transition Date.
- CEO and CFO Leadership Transitions On May 19, 2026, the Board of Directors (the "Board") of Omega Healthcare Investors, Inc. (the "Company") approved senior leadership transitions reflecting upcoming retirement plans and the Company's long-term leadership succession planning.
- On May 19, 2026, the Board and C. Taylor Pickett, the Company's Chief Executive Officer, mutually agreed that Mr. Pickett's employment with the Company and position as a member of the Board will terminate effective October 1, 2026 (the "CEO Transition Date").
- In addition, on May 19, 2026, the Board and Robert O. Stephenson mutually agreed that Mr. Stephenson's employment with the Company will terminate effective August 1, 2026 (the "CFO Transition Date").
- Mr. Gourmand (age 51) has served as the Company's President since January 1, 2025.
- Prior to that, Mr. Gourmand had served as the Company's Senior Vice President of Corporate Strategy & Investor Relations since October 2017.
- Prior to joining the Company, Mr. Gourmand spent ten years as an equity portfolio manager at Millennium Partners and Stevens Capital Management, three years as an equity research analyst at UBS and six years in the audit department of Deloitte, where he qualified as a Chartered Accountant and a Certified Public Accountant.
- He earned an LLB in Law from University College, London, and holds the Chartered Financial Analyst designation.
Tools for this story
Each opens in a new tab, filled in for Omega Healthcare Investors Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.